Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Role of extracellular LncRNA-SNHG14/miRNA-3940-5p/NAP12 mRNA in colorectal cancer.

Matboli M, Shafei AE, Ali MA, El-Din Ahmed TS, Naser M, Abdel-Rahman T, Anber N, Ali M.

Arch Physiol Biochem. 2019 Aug 9:1-7. doi: 10.1080/13813455.2019.1650070. [Epub ahead of print]

PMID:
31397210
2.

circRNAs (hsa_circ_00156, hsa_circ _000224, and hsa_circ _000520) are novel potential biomarkers in hepatocellular carcinoma.

Matboli M, Shafei AE, Ali MA, Ashry AM, Kamal KM, Agag MA, Reda I, Tash EF, Ali M.

J Cell Biochem. 2018 Nov 13. doi: 10.1002/jcb.28045. [Epub ahead of print]

PMID:
30426540
3.

Clinical significance of serum DRAM1 mRNA, ARSA mRNA, hsa-miR-2053 and lncRNA-RP1-86D1.3 axis expression in malignant pleural mesothelioma.

Matboli M, Shafei AE, Ali MA, Gaber AI, Galal A, Tarek O, Marei M, Khairy E, El-Khazragy N, Anber N, Abdel-Rahman O.

J Cell Biochem. 2019 Mar;120(3):3203-3211. doi: 10.1002/jcb.27586. Epub 2018 Oct 26.

PMID:
30362153
4.

Computational prediction of vaccine potential epitopes and 3-dimensional structure of XAGE-1b for non-small cell lung cancer immunotherapy.

Tarek MM, Shafei AE, Ali MA, Mansour MM.

Biomed J. 2018 Apr;41(2):118-128. doi: 10.1016/j.bj.2018.04.002. Epub 2018 May 21.

5.

Investigating miRNA-661 and ATG4-B mRNA expression as potential biomarkers for hepatocellular carcinoma.

Ali MA, Matboli M, El-Khazragy N, Saber O, El-Nakeep S, Abdelzaher HM, Shafei AE, Mostafa R.

Biomark Med. 2018 Mar;12(3):245-256. doi: 10.2217/bmm-2017-0273. Epub 2018 Feb 14.

PMID:
29441798
6.

Clinical evaluation of circulating miR-548a-3p and -20a expression in malignant pleural mesothelioma patients.

Matboli M, Shafei AE, Azazy AE, Reda M, El-Khazragy N, Nagy AA, Ali MA, Sobhi M, Abdel-Rahman O.

Biomark Med. 2018 Feb;12(2):129-139. doi: 10.2217/bmm-2017-0224. Epub 2018 Jan 17.

PMID:
29338319
7.

Mechanistic effects of mesenchymal and hematopoietic stem cells: New therapeutic targets in myocardial infarction.

Shafei AE, Ali MA, Ghanem HG, Shehata AI, Abdelgawad AA, Handal HR, ElSayed AS, Ashaal AE, Ali MM, El-Shal AS.

J Cell Biochem. 2018 Jul;119(7):5274-5286. doi: 10.1002/jcb.26637. Epub 2018 Mar 12. Review.

PMID:
29266431
8.

Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction.

Shafei AE, Ali MA, Ghanem HG, Shehata AI, Abdelgawad AA, Handal HR, Talaat KA, Ashaal AE, El-Shal AS.

J Gene Med. 2017 Dec;19(12). doi: 10.1002/jgm.2995. Epub 2017 Dec 8. Review.

PMID:
29044850
9.

Prenatal Exposure to Endocrine Disruptors and Reprogramming of Adipogenesis: An Early-Life Risk Factor for Childhood Obesity.

Shafei AE, Nabih ES, Shehata KA, Abd Elfatah ESM, Sanad ABA, Marey MY, Hammouda AAMA, Mohammed MMM, Mostafa R, Ali MA.

Child Obes. 2018 Jan;14(1):18-25. doi: 10.1089/chi.2017.0180. Epub 2017 Oct 11. Review.

PMID:
29019419
10.

Clinical significance of miRNA-autophagy transcript expression in patients with hepatocellular carcinoma.

Matboli M, Shafei AE, Shehata HH, Nabil N, Hossam N, Azazy AE, El-Tawdi AH, Abdel-Rahman O.

Biomark Med. 2017 Aug;11(8):641-656. doi: 10.2217/bmm-2017-0049. Epub 2017 Aug 3.

PMID:
28770611
11.

Epigenetic regulation of immune checkpoints: another target for cancer immunotherapy?

Ali MA, Matboli M, Tarek M, Reda M, Kamal KM, Nouh M, Ashry AM, El-Bab AF, Mesalam HA, Shafei AE, Abdel-Rahman O.

Immunotherapy. 2017 Jan;9(1):99-108. doi: 10.2217/imt-2016-0111. Review.

PMID:
28000527

Supplemental Content

Loading ...
Support Center